Placenta (Purasu-enta) Testing Standards and Analytical Methods

Abstract

Placenta is a functional ingredient extracted from mammalian placentas that has long held a significant position in Japan's health food market. Because raw material sources vary widely (porcine, equine, marine, etc.) and extraction processes differ, product quality can vary considerably. Objectively evaluating product quality through scientific testing has therefore become a core concern shared by industry regulators, manufacturers, and consumers alike. This paper systematically reviews the methodological framework applicable to placenta-based health food products — encompassing quantitative assay, purity assessment, heavy metal screening, and microbial limit testing — and analyzes the structure and interpretation of various types of test reports. The aim is to provide industry practitioners and consumers with objective, actionable reference guidance.

---

I. Regulatory and Certification Framework for Placenta-Based Health Foods in Japan

1.1 Regulatory Classification

In Japan, health food products containing placenta are regulated under the Food Sanitation Act and the Health Promotion Act. Placenta preparations are neither classified as pharmaceutical drugs nor as quasi-drugs (except where specifically approved), and their product labeling must not include any claims regarding therapeutic effects or medical efficacy. Labeling is restricted to verifiable dimensions such as ingredient information and nutrient content.

1.2 GMP Certification System

The Japan Health and Nutrition Food Association (JHNFA) has established a GMP (Good Manufacturing Practice) compliance certification system for health food manufacturers. Facilities holding JHNFA GMP Compliance Certification (GMP) are subject to periodic third-party audits covering raw material management, manufacturing processes, quality inspection, and traceability of records. This certification is currently one of the most important benchmarks for domestic consumers to verify the manufacturing compliance of health food products.

Certification numbers are publicly accessible, and consumers may use them to verify the certification status of a specific facility and determine whether the manufacturer's quality management meets the industry baseline requirements.

1.3 Labeling Standards

Under the Consumer Affairs Agency's Food Labeling Standards, placenta-based products must clearly state the following on the final product label:

• Raw material source (e.g., "" [porcine placenta extract], "" [equine placenta extract])
• Quantity per unit (mg/capsule, mg/recommended daily intake)
• Additive and allergen information
• Country of manufacture or place of processing

A label stating "Contains ○○ mg" that is not supported by corresponding test data is treated as a violation under Japan's advertising and labeling regulations. This requirement has been a direct driver of the need to standardize quantitative assay methods.

---

II. Quantitative Assay Methodology

In industry labeling, the "content" of placenta is generally expressed as total protein mass or the dry weight of placenta extract; quantitative labeling of specific bioactive molecules is rare. The following describes the mainstream assay methods and their applicable contexts.

2.1 Total Protein Quantification

The Kjeldahl method is a classical total nitrogen determination technique that converts nitrogen content to crude protein mass (conversion factor typically 6.25) through three steps: sample digestion, distillation, and titration. It is one of the legally prescribed methods for nutrient content labeling under Japan's Food Labeling Standards and is suitable for powdered and encapsulated placenta products. Its limitation is that non-protein nitrogen (such as amino acids and nucleic acids) is also measured, resulting in some degree of overestimation of protein content.

The BCA Protein Assay (Bicinchoninic Acid Assay) and Bradford method are colorimetric techniques commonly used in laboratory settings. They offer high sensitivity and convenient operation, making them suitable for rapid testing of liquid extracts. Both rely on a standard protein (typically BSA) to construct a working curve, and results are subject to sample matrix interference. They are not directly equivalent to the nutrient label values defined by regulation, but they are of significant reference value during the research and development phase.

Near-infrared spectroscopy (NIR) has been adopted by some manufacturers for incoming raw material batch control. Its advantages include being non-destructive, rapid, and amenable to online monitoring; however, it requires the development of a dedicated model specific to the placenta matrix, which presents a relatively high barrier to implementation.

2.2 Amino Acid Profile Analysis

Placenta is rich in a variety of amino acids, and its amino acid composition profile (Amino Acid Profile) can serve as an important indicator of raw material quality. The standard analytical procedure is as follows:

• 1. Hydrolysis: The sample is completely hydrolyzed with hydrochloric acid (6N HCl, 110°C, 24 h) to break peptide bonds and release free amino acids;
• 2. Derivatization: Post-column derivatization with ninhydrin or pre-column derivatization with o-phthalaldehyde (OPA);
• 3. Chromatographic separation: Ion exchange chromatography (IEC) or reversed-phase high-performance liquid chromatography (RP-HPLC);
• 4. Detection: UV/Vis detector or fluorescence detector (FLD).

Using HPLC-FLD as an example, the limit of quantitation (LOQ) typically reaches the 1 nmol/mL level, enabling precise absolute quantification of each individual amino acid component. This makes it a powerful tool for assessing raw material homogeneity and inter-batch consistency. A complete amino acid profile report should include absolute quantification results for 18 or more amino acids, along with notes on the hydrolysis method, reference standard sources, and chromatographic conditions.

2.3 Peptide Molecular Weight Distribution

The molecular weight distribution of polypeptides in placenta products is a key indicator for differentiating "crude extracts" from "refined hydrolysates." The standard method is size exclusion chromatography (SEC-HPLC), which separates components by molecular weight through a gel filtration column combined with UV detection, yielding a molecular weight distribution profile.

Results are typically expressed as the area percentage within molecular weight ranges (e.g., <1 kDa, 1–5 kDa, >5 kDa). A higher proportion of low molecular weight peptides (<1 kDa) is generally considered indicative of a more extensively hydrolyzed raw material. The consistency of this data with label descriptions such as "" (low-molecular-weight placenta) can be verified using this data.

---

III. Purity and Specificity Assessment

3.1 Non-Protein Impurity Screening

The placenta extraction process may leave residual lipids, pigments, nucleic acids, and other non-protein components. Fat content can be determined by Soxhlet extraction; nucleic acid residues can be initially assessed using the absorbance ratio at 260 nm/280 nm (A260/A280), with quantitative real-time PCR employed as a supplementary method when necessary.

3.2 Species Origin Identification

Because porcine and equine placenta are labeled differently in the market and occupy different price tiers, species identification is an important means of preventing raw material adulteration. Quantitative real-time PCR (qPCR) can be used to design primers and probes targeting species-specific mitochondrial genome sequences, enabling detection of species-specific DNA even in highly processed samples. It is currently the most sensitive and reliable method for species traceability. Some third-party testing organizations already offer this as a commercial testing service, capable of issuing species identification reports as a component of supply chain traceability documentation.

3.3 Residual Solvents

For products in which organic solvents are used as extraction aids, residual solvent levels must be tested by headspace gas chromatography (HS-GC) in accordance with the residual solvent limits stipulated in the Standards for Food Additives. Commonly monitored solvents include ethanol, ethyl acetate, and acetone. regulations set specific limit values for different solvents.

---

IV. Heavy Metal Testing Methods and Limit Standards

4.1 Primary Target Elements

Because placenta raw materials are derived from animal tissue, bioaccumulation effects make heavy metal monitoring particularly necessary. The primary elements monitored include:

• Lead (Pb): Neurotoxic; generally controlled at <0.1 mg/kg in foods (with variation across different food categories)
• Cadmium (Cd): Nephrotoxic; strong bioaccumulation potential
• Inorganic arsenic (As): Distinguished from organic arsenic; the inorganic form is more toxic
• Mercury (Hg): Particularly methylmercury; of special concern for marine-derived placenta
• Chromium (Cr), Nickel (Ni): Included in monitoring by some higher-standard products

4.2 Analytical Methods

Inductively coupled plasma mass spectrometry (ICP-MS) is currently the gold-standard method for simultaneous multi-element determination of heavy metals. Its limit of detection (LOD) can reach ng/L (ppt) levels, far exceeding the sensitivity of atomic absorption spectroscopy (AAS). The standard analytical procedure is as follows:

• 1. Sample digestion: Microwave-assisted acid digestion (HNO₃/H₂O₂ system) to completely mineralize the organic matrix;
• 2. Internal standard correction: Addition of internal standard elements such as In and Rh to correct for matrix effects and signal drift;
• 3. Multi-element scanning: More than 20 elements can be measured simultaneously in a single injection;
• 4. Result quantification: Via standard addition or external calibration.

Arsenic speciation analysis requires ion chromatography coupled with ICP-MS (IC-ICP-MS) upstream of detection to separate inorganic arsenic (As(III), As(V)) from organic arsenic (MMA, DMA) prior to individual quantification. Only inorganic arsenic is included in the safety assessment.

4.3 Key Points for Interpreting Test Reports

A compliant heavy metal test report should include:

• Accreditation information of the testing laboratory (ISO/IEC 17025 accreditation)
• Sample information (lot number, date of receipt)
• Test results for each element (mg/kg) along with their limits of detection (LOD) and limits of quantitation (LOQ)
• The standard or limit document on which the result determination is based
• A measurement uncertainty statement

If a report records only "ND" (Not Detected) without specifying the corresponding LOD, the consumer cannot assess the actual sensitivity of the "not detected" determination, and the reference value of such a report is limited.

---

V. Microbial Limit Testing

5.1 Test Items and Reference Standards

In accordance with Japan's Food Sanitation Act and relevant notifications from the Ministry of Health, Labour and Welfare, microbial testing of health food raw materials typically covers the following items:

Specific limits vary depending on product format (liquid/powder/capsule) and intended use claims. Companies typically establish internal control standards by referencing JHNFA voluntary standards or customer specification documents.

5.2 Methodological Trends

Conventional culture-based methods require 3–7 days to complete. PCR-based methods (such as real-time quantitative PCR and digital PCR) can detect and quantify specific pathogens within 24 hours and have been progressively adopted by some advanced facilities as part of rapid-release testing systems. When employing alternative methods validated under ISO 16140, equivalence must be confirmed through validation studies.

5.3 Special Risks Associated with Animal-Derived Raw Materials

As animal-derived materials, porcine and equine placenta require attention to prion risks and verification of viral inactivation efficacy. The Ministry of Health has established clear viral inactivation validation requirements for manufacturing processes involving animal-derived raw materials. Manufacturers should be able to provide corresponding process validation reports as part of their quality documentation.

---

VI. Third-Party Testing Organizations and Verification of Report Authenticity

6.1 Major Accredited Testing Organizations in Japan

Reports issued by testing organizations holding ISO/IEC 17025 accreditation (granted by the Japan Accreditation Board, JAB) carry the highest level of credibility. Consumers and procurement personnel can verify the accreditation scope and validity period of a testing organization through the JAB official database. Well-known third-party organizations include the Japan Food Research Laboratories (JFRL) and the General Incorporated Foundation Food and Environment Inspection Association, and their report numbers are fully traceable.

6.2 Distinguishing Between Raw Material Testing and Finished Product Testing

Batch-release quality documentation should clearly distinguish between:

• Raw material Certificate of Analysis (COA): Pertaining to incoming raw material batches, issued by the upstream supplier or obtained through independent commissioned testing;
• Finished product test report: Pertaining to the final product prior to shipment, confirming the quality status after formulation and manufacturing processes.

Both are essential components of a complete quality documentation system. A raw material COA alone cannot substitute for finished product testing.

---

VII. Actionable Guidance for Consumers

• 1. Verify GMP Certification: Check whether the manufacturing facility named on the product label holds JHNFA GMP Compliance Certification. The certification number can be individually verified in the JHNFA official online database, without relying on self-reported claims from the manufacturer.
• 2. Request Test Report Summaries: Reputable brands should be able to provide summaries or certificate numbers for third-party heavy metal and microbial test reports. If a website or product page contains no testing information whatsoever, treat this as a transparency warning signal.
• 3. Identify the Basis for Content Claims: When a label states "Contains ○○ mg of," confirm whether the figure represents total extract dry weight, total protein mass, or the content of a specific component. Values defined under different criteria cannot be compared across products; product specification documents must be consulted to make a meaningful judgment.
• 4. Pay Attention to Disclosed Species Origin: Determine whether the product clearly distinguishes between (porcine placenta) and (equine placenta), as the two differ in price and raw material scarcity. Higher-quality products should be able to provide species origin certification or supplier traceability documentation.
• 5. Check Report Date and Batch Correspondence: A valid test report must correspond to the production lot of the product being purchased. An outdated report (e.g., from two years prior) cannot attest to the quality status of the current batch.
• 6. Note the Detection Limit Behind "ND": A "Not Detected" finding in a test report is only meaningful as a reference when the LOD/LOQ is specified; the specific numerical values determine the credibility of the "not detected" declaration.

---

Conclusion

Quality assessment of placenta-based health food products is a comprehensive system encompassing analytical chemistry, food microbiology, molecular biology, and regulatory labeling. Quantitative assays provide a basis for raw material quantification; amino acid profiles and molecular weight distribution reveal the depth of raw material processing; heavy metal and microbial testing establish the safety baseline; and traceable reports issued by third-party organizations form the foundation upon which quality claims can be externally verified.

Consumers selecting such products need not become experts in analytical chemistry, but by acquiring the above conceptual framework, they can make independent judgments about a product's quality transparency through actionable steps — such as verifying GMP certification numbers, requesting testing documentation, and distinguishing between different labeling bases. In a health food market characterized by significant information asymmetry, manufacturers who proactively disclose verifiable testing data are taking the most substantively meaningful approach to building consumer trust.

---

*The testing methods and limit values referenced in this article are based on publicly available regulatory documents, analytical chemistry reference works, and established industry practice, and are provided for informational purposes only. Compliance testing of actual products must be entrusted to qualified professional organizations with the appropriate accreditation, and must comply with the version of applicable regulations in force at the time. This article does not constitute medical advice of any kind. Placenta-based products are classified as food, not drugs, and do not possess any function of preventing, treating, or diagnosing disease.*